Finance

Beta
Lists
SION:NASDAQ
Sionna Therapeutics Inc
$36.70
+0.60%
(+0.22) 1D
Jun 3, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SION...
Open
$36.50
High
$37.37
Low
$35.66
Mkt. cap
1.66B
Avg. vol.
394.71K
Volume
2.00
52-wk high
$48.44
52-wk low
$13.51
EPS
-$1.92
Shares outstanding
45.15M
No. of employees
59
Open
$36.50
High
$37.37
Low
$35.66
Mkt. cap
1.66B
Avg. vol.
394.71K
Volume
2.00
52-wk high
$48.44
52-wk low
$13.51
EPS
-$1.92
Shares outstanding
45.15M
No. of employees
59
Analyst outlook
Analyst Ratings
Based on 9 analysts giving stock ratings to SION in the past 3 months
Buy
Buy
7
Hold
1
Sell
1
12 month forecast
Based on 9 Wall Street analysts offering 12 month price targets for SION in the last 3 months.
Highest
Current $36.70
$63.00 (+71.66%)
Average
$51.71 (+40.90%)
Lowest
$23.00 (-37.33%)
News stories
From sources across the web
About Sionna Therapeutics Inc
CEO-
Employees59
Founded2019
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
15.38M
16.04M
15.17M
18.96M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.52M
7.76M
8.44M
10.64M
Operating expense
21.91M
23.80M
23.61M
29.60M
Total operating expenses
21.91M
23.80M
23.61M
29.60M
Operating income
-21.91M
-23.80M
-23.61M
-29.60M
Other non operating income
171.00K
71.00K
-
-
EBT including unusual items
-18.07M
-20.28M
-20.44M
-26.78M
EBT excluding unusual items
-18.07M
-20.28M
-20.44M
-26.78M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-18.07M
-20.28M
-20.44M
-26.78M
Net profit margin
-
-
-
-
Earnings per share
-0.41
-0.46
-0.46
-0.60
Interest and investment income
3.67M
3.46M
3.17M
2.82M
Interest expense
-
-
-
-
Net interest expenses
3.67M
3.46M
3.17M
2.82M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.76M
-23.62M
-23.46M
-29.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more